Download PDF
Thromb Haemost 1969; 22(03): 482-495
DOI: 10.1055/s-0038-1651385
Originalarbeiten-Original Articles-Travaux Originaux
Schattauer GmbH

Effect of Purified Vipera Palestinae Hemorrhagin on Blood Coagulation and Platelet Function[*]

L Grotto
1   Rogoff-Wellcome Medical Research Institute, Tel-Aviv University Medical School, Beilinson Hospital, Petah Tikva, Israel
,
Z Jerushalmy
1   Rogoff-Wellcome Medical Research Institute, Tel-Aviv University Medical School, Beilinson Hospital, Petah Tikva, Israel
,
A de Vries
1   Rogoff-Wellcome Medical Research Institute, Tel-Aviv University Medical School, Beilinson Hospital, Petah Tikva, Israel
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

Summary

Purified Vipera palestinae hemorrhagin (VPH) impairs thrombin formation, fibrinogen clottability, FSF activity, platelet clot retracting activity, ADP- and connective tissue-induced platelet aggregation and connective tissue - induced platelet ADP release. The effects of VPH became manifest or increased in intensity on incubation with the respective substrates prior to measurement of their activities. Inactivation of the VPH protease by DFP resulted in complete abolishment of the first four and partial inhibition of the last two of the above VPH activities.

Administration of VPH to guinea pigs caused widespread hemorrhages, associated with moderate hypofibrinogenemia but normal platelet count, clotting time and clot retraction. DFP-treated VPH caused hemorrhage without hypofibrinogenemia.

* This investigation was supported by the U.S.Army through its European Research Office, Contract No. D AJA 37-69-C-0252.


 

  • References

  • 1 Flexner S, Noguchi H. Univ. Pennsylvania. M. Bull. 15: 354 1902-1903 cit. ref. 2.
    PubMedGoogle Scholar
  • 2 Taube H. N, Essex H. E. Pathologie changes in the tissues of the dog following injections of rattle snake venom. Arch. Pathol. 24: 43 1937;
    PubMedGoogle Scholar
  • 3 Rechnic J, Trachtenberg P, Casper J, Moroz Ch, de Vries A. Afibrinogenemia and thrombocytopenia in guinea pigs following injection of Echis colorata venom. Blood 20: 735 1962;
    PubMedGoogle Scholar
  • 4 Djaldetti M, Joshua H, Bessler H, Rosen M, Gutglas H, de Vries A. Coagulation disturbance in the dog following Echis colorata venom inoculation. Hémostase 4: 323 1964;
    PubMedGoogle Scholar
  • 5 Rosenfeld G. Fibrinolysis by snake venoms. Sangre (Barcelona) 9: 352 1964;
    PubMedGoogle Scholar
  • 6 Reid H. A. Defibrination by Agkistrodon rhodostoma venom. In: Russell F. E. Animal Toxins. 323. Pergamon Press; Oxford and New York: 1967
    CrossrefGoogle Scholar
  • 7 Houssay B. A. Classification des actions des venins de serpents sur l’organisme animal. CR. Soc. Biol. 105: 308 1930;
    PubMedGoogle Scholar
  • 8 Kellaway C. H. Animal poisons. Ann. Rev. Biochem. 8: 541 1939;
    CrossrefPubMedGoogle Scholar
  • 9 Zeller E. A. Enzymes of snake venoms and their biological significance. Advanc. Enzymol. 5: 459 1948;
    PubMedGoogle Scholar
  • 10 Porges N. Snake venoms, their biochemistry and mode of action. Science 117: 47 1953;
    CrossrefPubMedGoogle Scholar
  • 11 Slotta K. Chemistry and biochemistry of snake venoms. Fortsch Chem. Org. Nat. 12: 406 1955;
    PubMedGoogle Scholar
  • 12 Kaiser E, Michl H. Die Biochemie der tierischen Gifte. 1st Ed.. 134. Franz Deuticke; Wien: 1958
    Google Scholar
  • 13 Maeno H, Mitsuhashi S, Sawai Y, Okonogi T. Studies on Habu snake venom: Enzymatic studies on the proteinase of Habu snake venom. Jap. J. Microbiol. 3: 131 1959;
    CrossrefPubMedGoogle Scholar
  • 14 Ohsaka A, Ikezawa H, Kondo H, Kondo S, Uchida N. Haemorrhagic activities of Habu venom and their relation to lethal toxicity, proteolytic activities and other pathological activities. Brit. J. exp. Pathol. 41: 478 1960;
    PubMedGoogle Scholar
  • 15 Twanaga S, Omori T, Oshima G, Suzuki T. Studies on snake venoms. XVI. Demonstration of a proteinase with hemorrhagic activity in the venom of Agkistrodon halys blomhoffii. J. Biochem. (Tokyo) 57: 392 1965;
    CrossrefPubMedGoogle Scholar
  • 16 Tu A. T, Toom P. M, Ganthavorn S. Hemorrhagic and proteolytic activities of Thailand snake venoms. Biochem. Pharmacol. 16: 2125 1967;
    CrossrefPubMedGoogle Scholar
  • 17 Tu A. T, Honima M, Hong B. S. Hemorrhagic, myonecrotic, thrombotic and proteolytic activities of viper venoms. Toxicon 6: 175 1969;
    CrossrefPubMedGoogle Scholar
  • 18 Leffkowitz M. Snakes and snake bite in Israel. Dapim Refuiim 13: 309 1954;
    PubMedGoogle Scholar
  • 19 Efrati P. Snake bite (vipera): Clinical picture and pathophysiology. Dapim Refuiim 13: 330 1954;
    PubMedGoogle Scholar
  • 20 Efrati P, Reif L. Clinical and pathological observations on sixty-five cases of viper bite in Israel. Amer. J. trop. Med. Hyg. 2: 1085 1953;
    PubMedGoogle Scholar
  • 21 Grotto L, Moroz Ch, de Vries A, Goldblum N. Isolation of Vipera palestinae hemorrhagin and distinction between its hemorrhagic and proteolytic activities. Biochem. biophys. Acta (Amst.) 133: 356 1967;
    CrossrefPubMedGoogle Scholar
  • 22 Jerushalmy Z, Zucker M. B. Some effects of fibrinogen degradation products (FDP) on blood platelets. Thrombos. Diathes. haemorrh. (Stuttg.) 15: 413 1966;
    PubMedGoogle Scholar
  • 23 Loewy A. G, Dunathan K, Kriel R, Wolfinger H. L. Fibrinase. I. Purification of substrate and enzyme. J. biol. Chem. 236: 2625 1961;
    PubMedGoogle Scholar
  • 24 Brecher G, Cronkite E. P. Morphology and enumeration of human blood platelets. J. appi. Physiol. 3: 365 1950;
    PubMedGoogle Scholar
  • 25 Wintrobe M. M. Clinical Hematology. 6th edition. 329. Lea & Febiger; Philadelphia: 1967
    Google Scholar
  • 26 Lee R. I, White P. D. A clinical study of the coagulation time of blood. Amer. J. med. Sci. 145: 495 1913;
    CrossrefPubMedGoogle Scholar
  • 27 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. Blackwell Scientific publications; Oxford: 1962
    Google Scholar
  • 28 Biggs R, Douglas A. S. Thromboplastin generation test. J. clin. Path. 6: 23 1953;
    CrossrefPubMedGoogle Scholar
  • 29 Ratnoff O. B, Menzie G. A new method for the determination of fibrinogen in small samples of plasma. J. Lab. clin. Med. 37: 316 1951;
    PubMedGoogle Scholar
  • 30 Latallo Z. S, Budzynski A. Z, Lipinski B, Kowalski E. Inhibition of thrombin and fibrin polymerization: two activities derived from plasmin digested fibrinogen. Nature (Lond.) 203: 1184 1964;
    CrossrefPubMedGoogle Scholar
  • 31 Lowry O. H, Rosebrough N. J, Farr A. L, Randall R. J. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193: 265 1951;
    PubMedGoogle Scholar
  • 32 Latallo Z. S, Fletcher A. P, Alkjaersig N, Sherry S. Influence of pH, ionic strength, neutral ions and thrombin on fibrin polymerization. Amer. J. Physiol. 202: 675 1962;
    PubMedGoogle Scholar
  • 33 Scheidegger J. J. Une micro-méthode de l’immunoélectrophorèse. Int. Arch. Allergy 7: 103 1955;
    CrossrefPubMedGoogle Scholar
  • 34 Ouchterlony O. Antigen-antibody reaction in gels: Acta path, microbiol. scand. 26: 507 1949;
    PubMedGoogle Scholar
  • 35 Davis B. J. Disc electrophoresis. II. Method and application to human serum proteins. Ann. N. Y. Acad. Sci. 121: 404 1964;
    PubMedGoogle Scholar
  • 36 Donnelly T. H, Laskowski M, Notley N, Scheraga H. A. Equilibria in the fibrinogen-fibrin conversion. II. Reversibility of the polymerization steps. Arch. Biochem. 56: 369 1955;
    CrossrefPubMedGoogle Scholar
  • 37 Lorand L, Rule N. G, Ong H. H, Furlanetto R, Jacobsen A, Downey J, Oner N, Bruner-Lorand J. Amine specificity in transpeptidation. Inhibition of fibrin cross-linking. Biochemistry 7: 1214 1968;
    CrossrefPubMedGoogle Scholar
  • 38 Cohen I, Djaldetti M, Karp M, de Vries A. Thrombocytosis with impaired platelet adhesiveness and platelet factor 3 availability. New Istanbul Contr. Clin. Sc. 9: 20 1966;
    PubMedGoogle Scholar
  • 39 Hovig T. Release of platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline ‘extract’ of tendons. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 264 1963;
    PubMedGoogle Scholar
  • 40 Haslam R. J. Role of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids. Nature (Lond.) 202: 765 1964;
    CrossrefPubMedGoogle Scholar
  • 41 Adam H. In: Methods of Enzymatic Analysis. 573 Edit. Bergmeyer H. U. Academic Press; New York: 1963
    Google Scholar
  • 42 Brons K, Gormsen J. Studies on platelet factor 3 activity. Scand. J. Haemat. 5: 300 1968;
    PubMedGoogle Scholar
  • 43 Poplawski A, Niewiarowski S. Method for determining antiheparin activity of platelets and erythrocytes. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 149 1965;
    PubMedGoogle Scholar
  • 44 Barnhart M. I. Immunochemistry. In: Blood Clotting Enzymology. 258. Edit. Seegers W. H. Academic Press; New York and London: 1967
    Google Scholar
  • 45 Meaume J. Les venins de serpents agents modificateurs de la coagulation sanguine. Toxicon 4: 25 1966;
    CrossrefPubMedGoogle Scholar
  • 46 De Vries A, Cohen I. Hemorrhagic and blood coagulation disturbing action of snake venoms. In: Recent advances in Blood Coagulation. 277. Edit. Poller L. J. A. Churchill Ltd.; 1969
    Google Scholar
  • 47 Alexander B, Rimon A, Katchalski E. Action of water-insoluble trypsin derivatives on fibrinogen clottability. Thrombos. Diathes. haemorrh. (Stuttg.) 16: 507 1966;
    PubMedGoogle Scholar
  • 48 Sanchez-Avalos J, Miller S. P. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states. Thrombos. Diathes. haemorrh. (Stuttg.) 19: 499 1968;
    PubMedGoogle Scholar
  • 49 Alkjaersig N, Fletcher A. P, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic states. II. The significance, mechanism and consequences of defective fibrin polymerization. J. clin. Invest. 41: 917 1962;
    CrossrefPubMedGoogle Scholar
  • 50 Bang U. M, Fletcher A. P, Alkjaersig N, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic states. Ill Demonstration of abnormal clot structure by electron microscopy. J. clin. Invest. 41: 935 1962;
    CrossrefPubMedGoogle Scholar
  • 51 Lipinski B, Wegrzynowicz Z, Budzynski A. Z, Kopéc M, Batallo Z. S, Kowalski E. Soluble unclottable complexes formed in the presence of fibrinogen degradation products during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombos. Diathes. haemorrh. (Stuttg.) 17: 65 1967;
    PubMedGoogle Scholar
  • 52 Kowalski E. Fibrinogen derivatives and their biologic activities. Seminars in Hematol. 5: 45 1968;
    PubMedGoogle Scholar
  • 53 Djaldetti M, Cohen I, Joshua H, Bessler H, Lorberbaum O, de Vries A. In vivo and in vitro inactivation of fibrin stabilizing factor by Echis colorata venom. Hémostase 5: 121 1965;
    PubMedGoogle Scholar
  • 54 Cross M. J. Effect of fibrinogen on the aggregation of platelets by adenosine diphosphate. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 524 1964;
    PubMedGoogle Scholar
  • 55 McLean J. R, Maxwell R. E, Hertler D. Fibrinogen and adenosine diphosphate-induced aggregation of platelets. Nature (Lond.) 202: 605 1964;
    CrossrefPubMedGoogle Scholar
  • 56 Chandler A. B, Stormorken H, Solum N. O, Gaarder A. An attempt to assay the anti-Willebrandfactor. Scand. J. clin. Lab. Invest. 17 (84) 129 1965;
    PubMedGoogle Scholar
  • 57 Solum N. O, Stormorken H. Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen and adrenaline. Scand. J. clin. Lab. Invest. 17 (Suppl. 84) 170 1965;
    PubMedGoogle Scholar
  • 58 Hovig T. The effect of various enzymes on the ultrastructure, aggregation, and clot retraction ability of rabbit blood platelets. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 84 1965;
    PubMedGoogle Scholar
  • 59 Schmid H. J, Jackson D. P, Conley C. L. Mechanism of action of thrombin on platelets. J. clin. Invest. 41: 543 1962;
    CrossrefPubMedGoogle Scholar
  • 60 Morse E. E, Jackson D. P, Conley C. L. Role of platelet fibrinogen in the reactions of platelets to thrombin. J. clin. Invest. 44: 809 1965;
    CrossrefPubMedGoogle Scholar